Marianne T. Sweetser
Marianne T. Sweetser publishes mostly in Molecular Biology, Immunology and Pathology and Forensic Medicine, on topics such as Amyloidosis: Diagnosis, Treatment, Outcomes, Porphyrin Metabolism and Disorders and Multiple Sclerosis Research Studies.
- World rank
- #191,481 of 7,710,434 ranked researchers
- Rank in United States
- #71,266 of 1,627,098
- Works
- 115
- Citations
- 13k
- Citations per work
- 112.5
What does Marianne T. Sweetser research?
Marianne T. Sweetser's work is mostly in Biochemistry, Genetics and Molecular Biology (26%), Medicine (24%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4538.9%
- Life Sciences4236.7%
- Health Sciences2824.4%
- Medicine2824.4%
- 1Molecular Biology26% of their works
- 2Immunology10% of their works
- 3Pathology and Forensic Medicine7% of their works
- 4Rheumatology7% of their works
- 5Oncology6% of their works
- 6Epidemiology4% of their works
Research topics
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Porphyrin Metabolism and Disorders
- Multiple Sclerosis Research Studies
- Heme Oxygenase-1 and Carbon Monoxide
- Skin and Cellular Biology Research
- Monoclonal and Polyclonal Antibodies Research
- Rheumatoid Arthritis Research and Therapies
- Neonatal Health and Biochemistry
Which keywords describe Marianne T. Sweetser's research?
The keywords of their largest research topics: Cardiac Amyloidosis, Transthyretin, Inflammation, Heme Biosynthesis, Vitamin B12, Diagnostic Criteria, Multiple Sclerosis and Carbon Monoxide.
- Glucose-6-Phosphate Dehydrogenase Deficiency
- Rheumatoid Arthritis
- Intermediate Filaments
- Biological Therapy
- Carbon Monoxide
- Diagnostic Criteria
- Heme Biosynthesis
- Transthyretin
- Cardiac Amyloidosis
- Inflammation
- Vitamin B12
- Multiple Sclerosis
- Heme Oxygenase-1
- Fc Receptors
- Keratins
- Therapeutic Antibodies
- Neonatal Jaundice
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cardiac Amyloidosis331 topic
- Transthyretin331 topic
- Inflammation222 topics
- Heme Biosynthesis171 topic
- Vitamin B12171 topic
- Diagnostic Criteria141 topic
- Multiple Sclerosis141 topic
- Carbon Monoxide131 topic
- Heme Oxygenase-1131 topic
- Biological Therapy91 topic
- Fc Receptors91 topic
- Intermediate Filaments91 topic
- Keratins91 topic
- Rheumatoid Arthritis91 topic
- Therapeutic Antibodies91 topic
- Glucose-6-Phosphate Dehydrogenase Deficiency71 topic
- Neonatal Jaundice71 topic
Where does Marianne T. Sweetser work?
Marianne T. Sweetser's main affiliation in the publication record is Alnylam Pharmaceuticals (United States), United States.
How many publications and citations does Marianne T. Sweetser have?
OpenAlex counts 115 works and 12,940 citations for Marianne T. Sweetser, an h-index of 38, ranking #191,481 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marianne T. Sweetser. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.